Applied Therapeutics says it received FDA's warning letter for genetic disease drug study
02/12/2024 23:10
Dec 2 (Reuters) - Applied Therapeutics APLT.O said on Monday it received a warning letter limited to a trial studying its genetic disease drug, after the U.S. health regulator declined to approve the treatment last week. (Reporting by Sriparna Roy in Bengaluru; Editing by Alan Barona) ((Sriparna.Roy@thomsonreuters.com))